Human Multipotent Adult Progenitor Cells Effectively Reduce GVHD While Preserving Graft-Versus-Leukemia Activity after Allogeneic BMT

被引：0
|
作者：
Metheny, Leland [1 ]
机构：
[1] Univ Hosp Cleveland, Cleveland, OH 44106 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2014年 / 14卷
关键词：
D O I：
10.1016/j.clml.2014.06.104
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
906
引用
收藏
页码：S158 / S158
页数：1
相关论文
共 50 条
  • [1] HUMAN MULTIPOTENT ADULT PROGENITOR CELLS EFFECTIVELY MODULATE ALLOREACTIVITY AFTER BONE MARROW TRANSPLANTATION REDUCING GVHD WHILE PRESERVING GRAFT-VERSUS-LEUKEMIA ACTIVITY
    Metheny, L. L.
    Eid, S.
    Keller, M.
    Van Devort, A.
    Lee, Z. H.
    Wilson, D.
    Auletta, J.
    Vant Hof, W.
    Paez, C.
    Cooke, K. R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S368 - S369
  • [2] Human multipotent adult progenitor cells effectively reduce graft-vs-host disease while preserving graft-vs-leukemia activity
    Metheny, Leland
    Eid, Saada
    Wuttisarnwattana, Patiwet
    Auletta, Jeffery J.
    Liu, Chen
    Van Dervort, Alana
    Paez, Conner
    Lee, ZhengHong
    Wilson, David
    Lazarus, Hillard M.
    Deans, Robert
    Vant Hof, Wouter
    Ktena, Yiouli
    Cooke, Kenneth R.
    STEM CELLS, 2021, 39 (11) : 1506 - 1519
  • [3] Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects
    Giver, CR
    Montes, RO
    Mittelstaedt, S
    Li, JM
    Jaye, DL
    Lonial, S
    Boyer, MW
    Waller, EK
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (10) : 616 - 632
  • [4] INVESTIGATIONS ON THE MECHANISMS OF GRAFT-VERSUS-LEUKEMIA (GVL) ACTIVITY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
    UHAREK, L
    GLASS, B
    GASSMANN, W
    ZEISS, M
    LOEFFLER, H
    MUELLERBUCHHOLTZ, W
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 731 - 731
  • [5] Icariin protects against acute graft-versus-host disease while preserving graft-versus-leukemia activity after allogeneic hematopoietic stem cell transplantation
    Su, Long
    Wei, Zhi-Feng
    Pi, Chen-Chen
    Qin, Tian-Xue
    Song, Fei
    Zhang, Yun-Wei
    Gao, Su-Jun
    PHYTOMEDICINE, 2024, 132
  • [6] INTERLEUKIN-2 PREVENTS GRAFT-VERSUS-HOST DISEASE WHILE PRESERVING THE GRAFT-VERSUS-LEUKEMIA EFFECT OF ALLOGENEIC T-CELLS
    SYKES, M
    ROMICK, ML
    SACHS, DH
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (15) : 5633 - 5637
  • [7] ENHANCEMENT OF GRAFT-VERSUS-LEUKEMIA (GVL) ACTIVITY BY NATURAL-KILLER (NK) CELLS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
    DEWITTE, T
    PREIJERS, F
    SCHATTENBERG, A
    WESSELS, J
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 581 - 581
  • [8] The role of interleukin-12 in preserving the graft-versus-leukemia effect of allogeneic CD8 T cells independently of GVHD
    Yang, YG
    Sykes, M
    LEUKEMIA & LYMPHOMA, 1999, 33 (5-6) : 409 - +
  • [9] Induction of graft-versus-leukemia reaction by cyclosporine (CsA) withdrawal as immunotherapy for relapsed leukemia after allogeneic BMT.
    Elmaagacli, AH
    Beelen, DW
    Trenn, G
    Schmidt, O
    Nahler, M
    Schaefer, UW
    BONE MARROW TRANSPLANTATION, 1999, 23 : S4 - S4
  • [10] Inhibition of RIP1 improves immune reconstitution and reduces GVHD mortality while preserving graft-versus-leukemia effects
    Prado-Acosta, Mariano
    Jeong, Seihwan
    Utrero-Rico, Alberto
    Goncharov, Tatiana
    Webster, Joshua D.
    Holler, Ernst
    Morales, George
    Dellepiane, Sergio
    Levine, John E.
    Rothenberg, Michael E.
    Vucic, Domagoj
    Ferrara, James L. M.
    SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (727)
12345